Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
RenovaCare has expanded its engagement with MCRA to continue to advance the Company’s FDA program.
read more
Synairgen has announce that recruitment of 100 hospitalised patients in its clinical trial of SNG001 in COVID-19 patients has now been completed.
read more
Pelican BioThermal announced the opening of a new network station and drop point in Incheon, South Korea as the country eyes pharmaceutical development as a primary driver of economic growth.
read more
Jonas Skjødt Møller is Rosholm’s successor as Chief Executive Officer effective July 1, 2020.
read more
The NIIMBL announces that they have received $8.9 million from the U.S. Department of Commerce's NIST.
read more
NewAge Industries has closed a deal to buy two building units at a location within seven miles of its southeastern Pennsylvania headquarters.
read more
Oncodesign and HitGen announced the start of a worldwide strategic alliance in Integrated Drug Discovery Services for the identification and progression of new chemical entities.
read more
SeraNovo has signed a second License Agreement with Carna Biosciences.
read more
Boehringer Ingelheim and Eli Lilly announced a research collaboration with DCRI for the prevention of Chronic heart failure and mortality after an acute Myocardial Infarction.
read more
Chi-Med and BeiGene have entered into a collaboration agreement to evaluate two of Chi-Med’s drug candidates, surufatinib and fruquintinib, with BeiGene’s anti-PD-1 antibody tislelizumab, for solid tumor cancers.
read more
Bio-Techne and Leica Biosystems have announced the European launch of the CE-IVD marked RNAscope™ In Situ Hybridization Detection Kit for automation on the BOND-III platform.
read more
ArcherDX announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase 3 clinical trials for AstraZeneca's targeted immuno-oncology therapeutics.
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing agreement with Humanigen for the fill finish supply of lenzilumab currently being studied in a trial for COVID-19.
read more
Catalent announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda.
read more
ADMA Biologics has commenced the collection of convalescent plasma through its wholly-owned subsidiary from individuals who have recovered from COVID-19.
read more